Payment overview · 2025
General Payments
$36.58
2 reported records · 2 companies
Healthcare provider profile · identity verified
Aaron I Salomon, PAC
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant · GOTHENBURG, NE · NPI 1689736019
Verified facts
What the public records show
CMS Open Payments records show Aaron I Salomon, PAC received $36.58 in general payments during 2025 across 2 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 50.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Armour Thyroid by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $18.30 | 50.0% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $18.28 | 50.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $36.58 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18.30 | 1 | 2025 |
Source payment records
|
|||||
| DALVANCE Normalized: dalvance |
Drug | ABBVIE INC. | $18.28 | 1 | 2025 |
Source payment records
|
|||||
| TEFLARO Normalized: teflaro |
Drug | ABBVIE INC. | $18.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | ARMOUR THYROID open payments reported associated product |
CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088 |
Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 742 | 118 |
| Omeprazole | Omeprazole | 647 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 635 | 95 |
| Pantoprazole Sodium | Pantoprazole Sodium | 524 | 77 |
| Gabapentin | Gabapentin | 424 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 387 | 65 |
| Losartan Potassium | Losartan Potassium | 318 | 51 |
| Klor-Con 10 | Potassium Chloride | 303 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 297 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 285 | 47 |
| Lisinopril | Lisinopril | 270 | 54 |
| Tamsulosin Hcl | Tamsulosin Hcl | 265 | 38 |
| Carvedilol | Carvedilol | 264 | 38 |
| Celecoxib | Celecoxib | 263 | 69 |
| Allopurinol | Allopurinol | 254 | 36 |
| Torsemide | Torsemide | 239 | 33 |
| Simvastatin | Simvastatin | 237 | 35 |
| Eliquis | Apixaban | 219 | 32 |
| Furosemide | Furosemide | 212 | 34 |
| Meloxicam | Meloxicam | 199 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 183 | 36 |
| Glimepiride | Glimepiride | 177 | 30 |
| Metformin Hcl | Metformin Hcl | 176 | 25 |
| Tramadol Hcl | Tramadol Hcl | 175 | 49 |
| Xarelto | Rivaroxaban | 169 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 145 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 145 | 25 |
| Mirtazapine | Mirtazapine | 140 | 16 |
| Buspirone Hcl | Buspirone Hcl | 127 | 17 |
| Lorazepam | Lorazepam | 126 | 25 |
| Clonazepam | Clonazepam | 121 | 14 |
| Alendronate Sodium | Alendronate Sodium | 116 | 18 |
| Famotidine | Famotidine | 116 | 22 |
| Potassium Chloride | Potassium Chloride | 115 | 27 |
| Spironolactone | Spironolactone | 115 | 17 |
| Warfarin Sodium | Warfarin Sodium | 113 | 19 |
| Bupropion Xl | Bupropion Hcl | 112 | 17 |
| Metformin Hcl Er | Metformin Hcl | 109 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 108 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 106 | 18 |
| Finasteride | Finasteride | 106 | 16 |
| Sertraline Hcl | Sertraline Hcl | 106 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 105 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 104 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 102 | 19 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 95 | 21 |
| Primidone | Primidone | 93 | 14 |
| Trazodone Hcl | Trazodone Hcl | 91 | 16 |
| Levofloxacin | Levofloxacin | 88 | 59 |
| Montelukast Sodium | Montelukast Sodium | 85 | 15 |
| Pregabalin | Pregabalin | 82 | 11 |
| Trulicity | Dulaglutide | 79 | 12 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 78 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 75 | 14 |
| Prednisone | Prednisone | 75 | 53 |
| Doxycycline Hyclate | Doxycycline Hyclate | 73 | 47 |
| Klor-Con M20 | Potassium Chloride | 71 | 13 |
| Jardiance | Empagliflozin | 70 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 14 |
| Midodrine Hcl | Midodrine Hcl | 64 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 62 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 61 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 59 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 59 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | suppressed |
| Azithromycin | Azithromycin | 54 | 49 |
| Tizanidine Hcl | Tizanidine Hcl | 54 | suppressed |
| Methylprednisolone | Methylprednisolone | 53 | 48 |
| Ventolin Hfa | Albuterol Sulfate | 53 | 13 |
| Myrbetriq | Mirabegron | 52 | suppressed |
| Ozempic | Semaglutide | 52 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 51 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 49 | 19 |
| Donepezil Hcl | Donepezil Hcl | 47 | suppressed |
| Eszopiclone | Eszopiclone | 47 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 45 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 45 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 44 | 11 |
| Farxiga | Dapagliflozin Propanediol | 43 | suppressed |
| Felodipine Er | Felodipine | 43 | suppressed |
| Memantine Hcl | Memantine Hcl | 42 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 41 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 41 | suppressed |
| Fluconazole | Fluconazole | 40 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 40 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 39 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | 11 |
| Dexamethasone | Dexamethasone | 37 | 34 |
| Divalproex Sodium | Divalproex Sodium | 37 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 37 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 37 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 36 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 36 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 36 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 35 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Gemfibrozil | Gemfibrozil | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 20 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 32 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 32 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Sotalol | Sotalol Hcl | 30 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | 11 |
| Bumetanide | Bumetanide | 28 | suppressed |
| Risperidone | Risperidone | 28 | suppressed |
| Aripiprazole | Aripiprazole | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 27 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 26 | 21 |
| Clindamycin Hcl | Clindamycin Hcl | 26 | 21 |
| Fentanyl | Fentanyl | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 26 | suppressed |
| Olanzapine | Olanzapine | 26 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 20 |
| Dutasteride | Dutasteride | 25 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Ranolazine Er | Ranolazine | 25 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 24 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Ezetimibe | Ezetimibe | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 23 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 23 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 23 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Chlorthalidone | Chlorthalidone | 22 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 21 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 21 | suppressed |
| Metolazone | Metolazone | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | 11 |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 17 | 16 |
| Naproxen | Naproxen | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | 14 |
| Ultiguard Safepack-Pen Needle | Pen Needle, Diabetic,disp Unit | 17 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Sucralfate | Sucralfate | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 15 | suppressed |
| Latanoprost | Latanoprost | 15 | suppressed |
| Mounjaro | Tirzepatide | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Buprenorphine | Buprenorphine | 14 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 14 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 14 | suppressed |
| Lansoprazole | Lansoprazole | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 13 |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 14 | suppressed |
| Vascepa | Icosapent Ethyl | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Cefprozil | Cefprozil | 13 | 12 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Lithium Carbonate Er | Lithium Carbonate | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Nystatin | Nystatin | 13 | suppressed |
| Olanzapine-Fluoxetine Hcl | Olanzapine/Fluoxetine Hcl | 13 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Sulfasalazine Dr | Sulfasalazine | 13 | suppressed |
| Testosterone | Testosterone | 13 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 13 | suppressed |
| Armour Thyroid | Thyroid,pork | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Gralise | Gabapentin | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 12 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $36.58 · 2 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, DALVANCE, TEFLARO | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error